Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             485 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormalities of sentence production in schizophrenia O'Donnell, B.F.
1994
35 9 p. 634-
1 p.
artikel
2 Abnormal P3 topography in schizotypal personality disorder Salisbury, D.F.
1994
35 9 p. 675-
1 p.
artikel
3 A bridging study of xanomeline tartrate in Alzheimer's disease (AD) Cutler, N.R.
1994
35 9 p. 628-
1 p.
artikel
4 Acetaldehyde induced DNA single strand breaks human lymphocytes Singh, N.P.
1994
35 9 p. 708-
1 p.
artikel
5 A controlled randomized trial of atypical depression: Study design and patient characteristics Jarrett, R.B.
1994
35 9 p. 617-
1 p.
artikel
6 Addition of lithium to haloperidol for refractory schizophrenia Wilson, W.H.
1994
35 9 p. 741-742
2 p.
artikel
7 Adolescent-onset psychosis and the schizophrenia spectrum Cornblatt, B.
1994
35 9 p. 660-
1 p.
artikel
8 A double-blind placebo controlled study with clonazepam in social phobia Ontiveros, A.
1994
35 9 p. 677-
1 p.
artikel
9 A double-blind study with paroxetine vs fluoxetine in depressive patients Ontiveros, A.
1994
35 9 p. 677-
1 p.
artikel
10 Affective spectrum disorders in convexity meningiomas Barak, Y.
1994
35 9 p. 728-
1 p.
artikel
11 A functional assessment of disability scale for tardive dyskinesia McCarthy, M.F.
1994
35 9 p. 731-
1 p.
artikel
12 Age dependent change of ventricular measures in schizophrenia: Cross-sectional analysis Frecska, E.
1994
35 9 p. 704-705
2 p.
artikel
13 A linkage marker for schizophrenia and related disorders Silverman, J.M.
1994
35 9 p. 740-741
2 p.
artikel
14 A longitudinal study of clinical and immune measures in schizophrenia Ganguli, R.
1994
35 9 p. 725-726
2 p.
artikel
15 Alpha-2 adrenoreceptor coupling in panic disorder: Effect of imipramine Gurguis, G.N.M.
1994
35 9 p. 739-
1 p.
artikel
16 Alpha-2 adrenoreceptor density and coupling to Gi protein in PTSD Gurguis, G.N.M.
1994
35 9 p. 739-
1 p.
artikel
17 Alphaxalone inhibits CRF- but not strychnine-potentiated acoustic startle Swerdlow, N.R.
1994
35 9 p. 630-631
2 p.
artikel
18 Alterations in neural activity during associative learning in humans Molchan, S.E.
1994
35 9 p. 658-659
2 p.
artikel
19 Amantadine versus biperiden: A double-blind study of treatment-efficacy in neuroleptic EPS Schubert, H.
1994
35 9 p. 732-
1 p.
artikel
20 Ambulatory measures in panic and generalized anxiety Hoehn-Saric, R.
1994
35 9 p. 737-738
2 p.
artikel
21 Amphetamine can slow reaction times Servan-Schreiber, D.
1994
35 9 p. 665-666
2 p.
artikel
22 Androgenic steroids: Effects on brain and behavior Rubinow, D.R.
1994
35 9 p. 619-620
2 p.
artikel
23 An ERP investigation of schizophrenic memory abnormalities Turetsky, B.
1994
35 9 p. 676-
1 p.
artikel
24 A neurohistological study of elderly institutionalized schizophrenic and affective disorder patients Golier, J.
1994
35 9 p. 703-
1 p.
artikel
25 A neuronal model for learned helplessness in the rat Petty, F.
1994
35 9 p. 705-706
2 p.
artikel
26 An overview of brain activation studies in mood disorders George, M.S.
1994
35 9 p. 658-
1 p.
artikel
27 Anti-aggressive effects of clozapine in children and adolescents Mandoki, M.W.
1994
35 9 p. 744-745
2 p.
artikel
28 Anti-cardiolipin AB in multicase families with schizophrenia Pinkhas, S.
1994
35 9 p. 726-
1 p.
artikel
29 Anticonvulsant effects of electroconvulsive therapy: Relationship to antidepressant activity Kales, H.
1994
35 9 p. 653-
1 p.
artikel
30 Antidepressant effects of treatments with metyrapone and hydrocortisone Checkley, S.A.
1994
35 9 p. 711-
1 p.
artikel
31 Antidepressants and ECS decrease the expression of neurotrophin-3 mRNA Smith, M.A.
1994
35 9 p. 670-671
2 p.
artikel
32 Antiglucocorticoid medication effects on specific depressive symptoms Wolkowitz, O.M.
1994
35 9 p. 678-679
2 p.
artikel
33 Antipsychotic drug therapy in schizophrenics: Studies of receptor occupancy Hirschowitz, J.
1994
35 9 p. 691-
1 p.
artikel
34 Anxiety as a factor in agitation in the demented institutionalized elderly: Randomized single blind treatment with azapirones versus neuroleptics Cantillon, M.
1994
35 9 p. 629-
1 p.
artikel
35 Anxiolytic effects of alcohol McLeod, D.R.
1994
35 9 p. 693-
1 p.
artikel
36 A pet activation study of selective attending during a stroop task Taylor, S.F.
1994
35 9 p. 683-
1 p.
artikel
37 A pet study of monozygotic twins discordant for frontal lobe injury: neurophysiological and cognitive sequelae Kirkby, B.S.
1994
35 9 p. 687-
1 p.
artikel
38 A pilot study of the efficacy and safety of A-81418 in reducing symptoms of nicotine withdrawal Grebb, J.A.
1994
35 9 p. 691-
1 p.
artikel
39 Apolipoprotein ɛ4 allele and familial risk in Alzheimer's disease Li, G.
1994
35 9 p. 664-
1 p.
artikel
40 Apomorphine disrupts prepulse facilitation and inhibition of startle Schwarzkopf, S.B.
1994
35 9 p. 630-
1 p.
artikel
41 A prospective study of continuation ECT Petrides, G.
1994
35 9 p. 652-653
2 p.
artikel
42 A randomized clinical trial of treatment for atypical depression: Preliminary results Schaffer, M.H.
1994
35 9 p. 617-618
2 p.
artikel
43 Are the regional differences in [3H]GBR 12935 binding clinically relevant? Hitri, A.
1994
35 9 p. 709-
1 p.
artikel
44 Are the “selective” serotonin reuptake inhibitors selectivein vivo? Petty, F.
1994
35 9 p. 643-
1 p.
artikel
45 A review of statistical design in controlled treatment trials in schizophrenia Stern, R.G.
1994
35 9 p. 741-
1 p.
artikel
46 Association studies in schizophrenia using a dopamine D3 receptor gene polymorphism Nimgaonkar, V.L.
1994
35 9 p. 669-
1 p.
artikel
47 A study of HPA axis function in Alzheimer's disease Schweitzer, I.
1994
35 9 p. 629-
1 p.
artikel
48 A study of morphine preference in inbred mouse strains Berrettini, W.
1994
35 9 p. 708-
1 p.
artikel
49 A subgroup of schizophrenics may show “hyperpriming” on a semantic priming experiment Vinogradov, S.
1994
35 9 p. 635-
1 p.
artikel
50 Attentional abnormalities in early onset substance abuse: A marker of alcohol abuse Pogge, D.L.
1994
35 9 p. 707-
1 p.
artikel
51 Attentional effects of single dose triazolam Carter, C.S.
1994
35 9 p. 641-
1 p.
artikel
52 Attentional effects on a test of ecological memory in schizophrenia White, A.O.
1994
35 9 p. 634-
1 p.
artikel
53 Attention and motion perception Stuve, T.
1994
35 9 p. 634-
1 p.
artikel
54 Author index to abstracts 1994
35 9 p. 748-756
9 p.
artikel
55 Autoantibodies in aging: Possible relation to decline in cognitive ability Radic, M.Z.
1994
35 9 p. 728-
1 p.
artikel
56 Basal ganglia volume in schizophrenia: an MR study Hokama, H.
1994
35 9 p. 721-
1 p.
artikel
57 Behavioral effects of risperidone Zamrini, E.Y.
1994
35 9 p. 744-
1 p.
artikel
58 Beta-adrenoreceptor density and coupling to GS protein in PTSD Gurgius, G.N.M.
1994
35 9 p. 654-
1 p.
artikel
59 Biphasic effects of metergoline in fluoxetine-treated OCD patients Greenberg, B.D.
1994
35 9 p. 738-
1 p.
artikel
60 Blood pressure and heart rate regulation in young and elderly healthy controls in comparison to depressed patients under baseline and mental stress condition Gotthardt, U.
1994
35 9 p. 648-
1 p.
artikel
61 Blood serotonin and disruptive behavior disorders in juvenile OCD Hanna, G.L.
1994
35 9 p. 646-
1 p.
artikel
62 Blunted paralimbic resting and procaine-activated rCBF in healthy females compared to males Ketter, T.A.
1994
35 9 p. 648-
1 p.
artikel
63 Brain glucose uptake changes with total sleep deprivation (SD): — relationship to sleep and temperature Dubé, S.
1994
35 9 p. 663-
1 p.
artikel
64 Brain lithium levels measured by MRS: Variability during maintenance treatment in bipolar disorder Sachs, G.S.
1994
35 9 p. 626-
1 p.
artikel
65 Brain noradrenergic neurons, stress and post-traumatic stress disorder Aston-Jones, G.
1994
35 9 p. 709-
1 p.
artikel
66 Brain volume abnormalities in schizophrenia are not related to age of onset Lim, K.O.
1994
35 9 p. 719-
1 p.
artikel
67 Bromocriptine impairs P50 auditory sensory gating in normal control subjects Adler, L.E.
1994
35 9 p. 630-
1 p.
artikel
68 Catecholaminergic axons in the entorhinal cortex of schizophrenics and controls Akil, M.
1994
35 9 p. 716-
1 p.
artikel
69 Cation transport mediated by Na, K-ATPase in lymphoblastoma cells from patients with bipolar I disorder, their relatives, and unrelated controls Swann, A.C.
1994
35 9 p. 729-730
2 p.
artikel
70 Cell-mediated immunity in depression Weizman, R.
1994
35 9 p. 726-
1 p.
artikel
71 Central inhibitory deficits in OCD and tourette syndrome Swerdlow, N.R.
1994
35 9 p. 664-
1 p.
artikel
72 Cerebral blood flow after inhalation of 35 percent carbon dioxide Beck, D.
1994
35 9 p. 647-
1 p.
artikel
73 Cerebral metabolic correlates of monitoring the source of remembered information Andreason, P.J.
1994
35 9 p. 684-
1 p.
artikel
74 Challenge tests in panic disorder for NA and 5HT Kahn, R.S.
1994
35 9 p. 621-
1 p.
artikel
75 Changes in pattern of acceleration of behavior in patients with Alzheimer's disease Fujimoto, T.
1994
35 9 p. 629-
1 p.
artikel
76 Changes in striatal ultrastructure in rats with haldol induced VCM's Roberts, R.C.
1994
35 9 p. 690-
1 p.
artikel
77 Characterization of a schizophrenic brain collection Healy, D.J.
1994
35 9 p. 717-718
2 p.
artikel
78 Characterization of individuals who initiate domestic violence Bitler, D.A.
1994
35 9 p. 697-
1 p.
artikel
79 Cholinergic challenge and affective instability in personality disorder patients Steinberg, B.J.
1994
35 9 p. 740-
1 p.
artikel
80 Chronic cocaine abuse is associated with peripheral nerve damage Cadet, J.L.
1994
35 9 p. 707-708
2 p.
artikel
81 Chronic I.C.V. infusion with monoclonal anti-NPFF IgG up-regulates mu opioid binding sites in rat brain: An autoradiographic study Goodman, C.B.
1994
35 9 p. 727-
1 p.
artikel
82 Chronobiological studies of mood and the menstrual cycle Parry, B.L.
1994
35 9 p. 661-662
2 p.
artikel
83 Chronology of principal and comorbid syndromes in first-episode psychosis Strakowski, S.M.
1994
35 9 p. 623-624
2 p.
artikel
84 Circadian HPA hormones and immune measures in depressed patients: Comparisons with normal controls Kronfol, Z.
1994
35 9 p. 618-
1 p.
artikel
85 Clinical status of early-onset adolescent psychotic in-patients Reich, M.
1994
35 9 p. 696-
1 p.
artikel
86 Clinical use of ketoconazole in hypercortisoluric depressives Ravaris, C.L.
1994
35 9 p. 679-
1 p.
artikel
87 Clonazepam induced sexual dysfunction in male veterans with PTSD Fossey, M.D.
1994
35 9 p. 656-
1 p.
artikel
88 Clozapine response in chronic schizophrenia not associated with brain morphology on MRI: A preliminary report Aronowitz, J.
1994
35 9 p. 742-
1 p.
artikel
89 Clozapine response varies in deficit vs non-deficit schizophrenic subjects Conley, R.
1994
35 9 p. 746-
1 p.
artikel
90 Clozapine treatment in patients with chronic schizophrenia: efficacy and predictors of response Su, T.P.
1994
35 9 p. 745-746
2 p.
artikel
91 Clozapine treatment of children and adolescents Kowatch, R.A.
1994
35 9 p. 747-
1 p.
artikel
92 Cognitive control functions in memory-impaired subjects: A neuropharmacological model Weingartner, H.
1994
35 9 p. 640-
1 p.
artikel
93 Cognitive impairment and clinical symptoms in geriatric schizophrenic inpatients and outpatients Putnam, K.M.
1994
35 9 p. 639-
1 p.
artikel
94 Co-localization of neurotensin receptor mRNA within dopaminergic neurons Cho, T.
1994
35 9 p. 689-
1 p.
artikel
95 Comorbidity of cocaine abuse and schizophrenia: An examination of clinical functioning across an acute episode Serper, M.R.
1994
35 9 p. 692-
1 p.
artikel
96 Comorbid panic disorder in a bipolar family study MacKinnon, D.F.
1994
35 9 p. 728-729
2 p.
artikel
97 Comparison of dual-echo and SPGR MRI for cerebral gray-white segmentation Peng, L.W.
1994
35 9 p. 720-
1 p.
artikel
98 Comparison of risperidone and clozapine on clinical and cognitive functions in psychotic disorders Daniel, D.G.
1994
35 9 p. 667-
1 p.
artikel
99 Compulsive and stereotyped behavior disorders in mentally retarded patients Lewis, M.H.
1994
35 9 p. 643-644
2 p.
artikel
100 Confirmatory factor analysis to test schizophenic models Peralta, V.
1994
35 9 p. 695-
1 p.
artikel
101 Correlates of1H-magnetic resonance spectroscopy in schizophrenia Buckley, P.
1994
35 9 p. 683-
1 p.
artikel
102 Cortisol and prolactin response to fenfluramine in suicidal patients Sirota, P.
1994
35 9 p. 711-712
2 p.
artikel
103 CRF and the locus coeruleus: biological substrates of PTSD Valentino, R.J.
1994
35 9 p. 709-
1 p.
artikel
104 CSF HVA:5HIAA ratio increases with antipsychotic response to clozapine Risch, S.C.
1994
35 9 p. 742-743
2 p.
artikel
105 Cutaneous and ocular side effects with chlorpromazine therapy Wolf, M.E.
1994
35 9 p. 743-
1 p.
artikel
106 3D atlas of the human brain from MR data: a new teaching and research resource Shenton, M.E.
1994
35 9 p. 721-
1 p.
artikel
107 Decreased lumbar bone mineral density in patients with major depression Schweiger, U.
1994
35 9 p. 730-
1 p.
artikel
108 Decreased numbers of hipocampal nicotinic receptors in schizophrenia Hall, M.
1994
35 9 p. 700-
1 p.
artikel
109 Decreased PHA stimulated IL-2 production in drug-naive schizophrenics Ganguli, R.
1994
35 9 p. 708-
1 p.
artikel
110 Decreased platelet 5-HT uptake sites in PTSD: Association with state and trait anxiety Fichtner, C.G.
1994
35 9 p. 656-657
2 p.
artikel
111 Decreased synaptophysin immunoreactivity in prefrontal cortex of schizophrenics Glantz, L.A.
1994
35 9 p. 717-
1 p.
artikel
112 Defective response inhibition (motor distractibility) in ADHD Voeller, K.K.S.
1994
35 9 p. 724-
1 p.
artikel
113 Deficit in verbal learning in schizotypal personality disorder Voglmaier, M.M.
1994
35 9 p. 741-
1 p.
artikel
114 Dehydroepiandrosterone (DHEA) and memory in depressed patients Reus, V.I.
1994
35 9 p. 642-
1 p.
artikel
115 Delayed word recall in aged schizophrenia Herrera, J.
1994
35 9 p. 638-
1 p.
artikel
116 Demographic and clinical profile of 110 hairpullers Cohen, L.J.
1994
35 9 p. 698-
1 p.
artikel
117 Depression in parkinson's disease: A pet study Ring, H.A.
1994
35 9 p. 685-686
2 p.
artikel
118 Depression in severe chronic schizophrenia Tapp, A.
1994
35 9 p. 667-
1 p.
artikel
119 Depth perception in schizophrenia Pallanti, S.
1994
35 9 p. 637-638
2 p.
artikel
120 Developmental expression of serotonin-receptor subtypes in rat hippocampus Zhang, L.
1994
35 9 p. 643-
1 p.
artikel
121 Development and initial validation of a measure of alcohol urges in abstinent alcoholics Bohn, M.J.
1994
35 9 p. 693-
1 p.
artikel
122 Diabetes mellitus and cognitive impairment in schizophrenia Mukherjee, S.
1994
35 9 p. 640-
1 p.
artikel
123 Differential diagnosis of dementia versus depression using response bias Corwin, June
1994
35 9 p. 627-
1 p.
artikel
124 Diminished physiological flexibility in anxiety disorders Hoehn-Saric, R.
1994
35 9 p. 737-
1 p.
artikel
125 Distribution of stem cell factor mRNA in adult rat brain Wong, M.L.
1994
35 9 p. 732-
1 p.
artikel
126 Diurnal MHPG, cortisol and autonomic rhythms in acute and remitted depression Steinberg, B.J.
1994
35 9 p. 669-
1 p.
artikel
127 Does semantic “hyperpriming” correlate with impaired sensory gating in schizophrenia? Vinogradov, S.
1994
35 9 p. 615-616
2 p.
artikel
128 Do neurologically impaired schizophrenics have abnormal spect scans? Masand, P.
1994
35 9 p. 623-
1 p.
artikel
129 Dopamine autoreceptors in the human midbrain Meador-Woodruff, J.H.
1994
35 9 p. 688-689
2 p.
artikel
130 Dopamine D3 receptor polymorphism and response to apomorphine challenge Duval, F.
1994
35 9 p. 670-
1 p.
artikel
131 Dopamine metabolism in the 1st-degree relatives of schizophrenic probands Amin, F.
1994
35 9 p. 690-691
2 p.
artikel
132 Dopamine receptor gene expression in the human medial temporal lobe Meador-Woodruff, J.H.
1994
35 9 p. 689-
1 p.
artikel
133 Dopamine re-uptake blockers and drug seeking behavior Glowa, J.R.
1994
35 9 p. 625-
1 p.
artikel
134 Dopaminergic regulation of cortical prodynorphin derived peptides Healy, D.J.
1994
35 9 p. 690-
1 p.
artikel
135 Do polydipsia patients display other repetitive behaviors? De Leon, J.
1994
35 9 p. 698-
1 p.
artikel
136 Double blind trial of a GNRH agonist and an oral contraceptive in PMS / LLPDD Feinberg, M.
1994
35 9 p. 667-
1 p.
artikel
137 D2 substrates of a measure that predicts atypical antipsychotic potency Swerdlow, N.R.
1994
35 9 p. 662-
1 p.
artikel
138 Dynorphin antibodies bind microbial protein sequences that mimic dynorphin Roy, B.
1994
35 9 p. 727-
1 p.
artikel
139 Echo planar MRI of schizophrenics and normal controls during word production Yurgelun-Todd, D.A.
1994
35 9 p. 622-623
2 p.
artikel
140 ECS effects on neuronal DNA strand breaks Khan, A.
1994
35 9 p. 664-
1 p.
artikel
141 ECT normalizes circadian thermoregulation in depression Szuba, M.P.
1994
35 9 p. 652-
1 p.
artikel
142 Effect of cocaine on D3 and D4 receptor expression in the human striatum Meador-Woodruff, J.H.
1994
35 9 p. 670-
1 p.
artikel
143 Effect of commonly used therapeutic dosages of glucocorticoids on memory Keenan, P.A.
1994
35 9 p. 665-
1 p.
artikel
144 Effect of cortical gray matter, attention and schizophrenia on P300 amplitude Ford, J.M.
1994
35 9 p. 705-
1 p.
artikel
145 Effect of menstrual cycle phase on biochemical and behavioral response to m-CPP Su, T.P.
1994
35 9 p. 661-
1 p.
artikel
146 Effect of palatable food intake on response to pain Krahn, D.
1994
35 9 p. 736-
1 p.
artikel
147 Effect of testing frequency on MK-801 induced “popping” and ataxia in mice Hitri, A.
1994
35 9 p. 662-663
2 p.
artikel
148 Effects of Alprazolam on cognitive function of schizophrenics Hoff, A.L.
1994
35 9 p. 745-
1 p.
artikel
149 Effects of anticholinergic modulation on polysomnographic abnormalities in schizophrenia Tandon, R.
1994
35 9 p. 673-
1 p.
artikel
150 Effects of antidepressant medication on rCBF in late-life depression Nobler, M.S.
1994
35 9 p. 712-
1 p.
artikel
151 Effects of brief neuroleptic discontinuation in chronic hospitalized schizophernic patients: no evidence for supersensitivity psychosis Tapp, A.
1994
35 9 p. 744-
1 p.
artikel
152 Effects of desipramine on 5-HT function in depressed patients and healthy subjects Leatherman, M.E.
1994
35 9 p. 645-
1 p.
artikel
153 Effects of medical oophorectomy and hormone replacement on mood, sexual interest, cognition. And cerebral blood flow Schmidt, P.J.
1994
35 9 p. 619-
1 p.
artikel
154 Effects of perinatal hypoxia on brain and behavior: Relevance to schizophrenia Schwarzkopf, S.B.
1994
35 9 p. 725-
1 p.
artikel
155 Effects of sound intensity on auditory P50 gating in schizophrenics and normals Griffith, J.
1994
35 9 p. 630-
1 p.
artikel
156 Effects of the novel cholinomimetic SDZ ENS 163 on scopolamine-induced cognitive impairment Cutler, N.R.
1994
35 9 p. 641-
1 p.
artikel
157 Effects of yohimbine on cerebral blood flow in humans: a pet study Cameron, O.G.
1994
35 9 p. 646-647
2 p.
artikel
158 Efficacy trial of A-75200 in patients with major depressive disorder Cutler, N.R.
1994
35 9 p. 679-
1 p.
artikel
159 Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: Is the panss a valid scale? Harvey, P.D.
1994
35 9 p. 695-
1 p.
artikel
160 Endocrine responses to antiglucocorticoid strategies in refractory depression Pearson Murphy, B.E.
1994
35 9 p. 618-
1 p.
artikel
161 Endocrine responses to D,L- and D-fenfluramine in psychiatry Duval, F.
1994
35 9 p. 646-
1 p.
artikel
162 Entorhinal cortex volume in schizophrenia: a controlled MRI study Sharma, S.
1994
35 9 p. 718-
1 p.
artikel
163 EP and neuropsychological correlates of premorbid adjustment in schizophrenia Levitt, J.J.
1994
35 9 p. 617-
1 p.
artikel
164 Epidemiological and clinical factors associated with polydipsia in a state hospital de Leon, J.
1994
35 9 p. 698-699
2 p.
artikel
165 Evidence for an 18p11 bipolar susceptibility locus Berrettini, W.
1994
35 9 p. 626-
1 p.
artikel
166 Evidence for hippocampal volume atrophy (not hypoplasia) in schizophrenia Nasrallah, H.A.
1994
35 9 p. 704-
1 p.
artikel
167 Evoked potential measures of language processing in schizophrenia Niznikiewicz, M.A.
1994
35 9 p. 675-
1 p.
artikel
168 Expression of the 5TH1A and 5HT2 receptors in the human brain Marazziti, D.
1994
35 9 p. 717-
1 p.
artikel
169 Extended release (ER) formulation of buspirone in generalized anxiety disorder Cutler, N.R.
1994
35 9 p. 680-
1 p.
artikel
170 Factors determining the efficacy of morphine as a conditioned stimulus Bormann, N.M.
1994
35 9 p. 734-
1 p.
artikel
171 Familial risk of schizophrenia and ventricular size on CT Golier, J.A.
1994
35 9 p. 720-
1 p.
artikel
172 Familial status differentiates smooth pursuit eye movements of schizophrenics Schwartz, B.
1994
35 9 p. 674-
1 p.
artikel
173 Fetal brain development of twins assessedIn utero by ultrasound Gilmore, J.H.
1994
35 9 p. 623-
1 p.
artikel
174 Fetal rat schizophrenia model: DA, ACh, nitric oxide challenge Lyon, M.
1994
35 9 p. 707-
1 p.
artikel
175 Free radicals and neurological signs in chronic schizophrenic patients Reddy, R.
1994
35 9 p. 699-700
2 p.
artikel
176 Frontal and temporal lobe brain volumes in schizophrenia: relationship to symptomatology and clinical subtype Turetsky, B.
1994
35 9 p. 723-
1 p.
artikel
177 Functional correlates of gray matter volume deficits in schizophrenia Sullivan, E.V.
1994
35 9 p. 719-
1 p.
artikel
178 Functional imaging with spect of cognitive activity in schizotypals Trestman, R.L.
1994
35 9 p. 683-684
2 p.
artikel
179 Functional MRI of sensory, motor and cognitive activity McCarthy, G.
1994
35 9 p. 657-
1 p.
artikel
180 Gender and reproductive effects on cognitive function Keenan, P.
1994
35 9 p. 620-
1 p.
artikel
181 Gender-related differences in serotonin activity: implications for understanding the eating disorders Kaye, W.
1994
35 9 p. 619-
1 p.
artikel
182 Genetic differences in behavioral response to neonatal hippocampal damage in rats Lipska, B.K.
1994
35 9 p. 706-
1 p.
artikel
183 GH response to TRH in multicase families with schizophrenia Sirota, P.
1994
35 9 p. 649-
1 p.
artikel
184 Glutamate receptor autoradiography of postmortem basal ganglia in schizophrenia Noga, J.T.
1994
35 9 p. 735-
1 p.
artikel
185 Gonadotropin-releasing-hormone agonist induces depression in women Toren, P.
1994
35 9 p. 649-650
2 p.
artikel
186 G proteins: Molecular targets for gonadal steroids Manji, H.K.
1994
35 9 p. 620-
1 p.
artikel
187 Gray and white matter volumes in schizophrenia and bipolar disorder Zipursky, R.B.
1994
35 9 p. 719-720
2 p.
artikel
188 Gray matter volume deficits in first-episode schizophrenia Keshavan, M.S.
1994
35 9 p. 713-
1 p.
artikel
189 Greater increases in cocaine cue-induced craving and pupillary size in cocaine addicts endorsing cocaine-induced paranoia Rosse, R.B.
1994
35 9 p. 693-
1 p.
artikel
190 [3H]-GABA and [3H]-Flunitrazepam binding are differently affected by handling stress and phencyclidine Lillrank, S.M.
1994
35 9 p. 734-735
2 p.
artikel
191 High CSF predicts earlier relapse in schizophrenia: Survival analysis Forman, S.D.
1994
35 9 p. 702-
1 p.
artikel
192 Higher beta adrenoreceptor density and supercoupling to GS protein in panic disorder Gurguis, George N.M.
1994
35 9 p. 739-
1 p.
artikel
193 High lethality suicidal acts in depression & impaired serotonin function Malone, K.M.
1994
35 9 p. 668-669
2 p.
artikel
194 High prevalence of syndrome X in chronic schizophrenic patients Mukherjee, S.
1994
35 9 p. 701-
1 p.
artikel
195 High resolution MR imaging of the hippocampal region in schizophrenia: a new methodology with preliminary results Wible, C.G.
1994
35 9 p. 722-723
2 p.
artikel
196 HMPAO spect brain imaging in treatment-resistant depression Hornig-Rohan, M.
1994
35 9 p. 687-
1 p.
artikel
197 HMPAO spect identifies schizophrenic patients with stimulant abuse Bell, K.M.
1994
35 9 p. 624-
1 p.
artikel
198 Hostile/impulsive traits in addicts: 5-HT behavioral pharmacology Handelsman, L.
1994
35 9 p. 625-
1 p.
artikel
199 How do sex hormones affect nerve cells? McEwen, B.S.
1994
35 9 p. 619-
1 p.
artikel
200 [3H]Paroxetine binding in human brain: Comparison with [3H]cyanoimipramine Joyce, J.N.
1994
35 9 p. 728-
1 p.
artikel
201 5-HT3 receptors and the nausea and prolactin responses to clomipramine challenge Leatherman, M.E.
1994
35 9 p. 645-
1 p.
artikel
202 Hyperactivity and reduction in sustained behavior following perinatal hypoxia McCoy, L.
1994
35 9 p. 724-725
2 p.
artikel
203 Hypothalamic-pituitary-adrenal activity in panic disorder Abelson, J.L.
1994
35 9 p. 649-
1 p.
artikel
204 Hypothalamic-pituitary-adrenal axis reactivity to insulin-induced hypoglycemia in women at different phases of the menstrual cycle Long, T.
1994
35 9 p. 650-
1 p.
artikel
205 Identity of the primary structure of the human platelet and brain serotonin 5-HT2A receptors Cook, E.H.
1994
35 9 p. 670-
1 p.
artikel
206 Imipramine plasma concentrations and response in panic disorder Mavissakalian, M.
1994
35 9 p. 677-678
2 p.
artikel
207 Immune function in cushing's syndrome: Relation to HPA axis hormones Kronfol, Z.
1994
35 9 p. 651-
1 p.
artikel
208 Impaired auditory sensory (“Echoic”) memory in schizophrenia Strous, R.D.
1994
35 9 p. 636-
1 p.
artikel
209 Impaired cognitive processing within 1° auditory cortex in schizophrenia Javitt, D.C.
1994
35 9 p. 615-
1 p.
artikel
210 Impaired memory and attention in schizophrenia multiplex families Shedlack, K.J.
1994
35 9 p. 659-660
2 p.
artikel
211 Impaired startle gating in Huntington's disease: Neuropsychological correlates Swerdlow, N.R.
1994
35 9 p. 632-
1 p.
artikel
212 Increased hippocampal volume in bipolar disorder Kemmerer, M.
1994
35 9 p. 626-
1 p.
artikel
213 Independence of morphologic markers in schizophrenia Bilder, R.M.
1994
35 9 p. 720-721
2 p.
artikel
214 Individual variation of dopamine D2 receptors with I-123-IBZM spect Coppola, R.
1994
35 9 p. 687-
1 p.
artikel
215 Induction of APP results in its secretion and production of B-amyloid in subcortically lesioned rats Wallace, W.
1994
35 9 p. 671-
1 p.
artikel
216 Information processing deficits in mood disorder: An ERP study Saito, H.
1994
35 9 p. 672-
1 p.
artikel
217 Information processing deficits in schizophrenia: An ERP study Matsuoka, H.
1994
35 9 p. 672-
1 p.
artikel
218 Information processing deficits in temporal lobe epilepsy: An ERP study Ueno, T.
1994
35 9 p. 672-
1 p.
artikel
219 Interaction between 5-HT and NE in human anxiety Goddard, A.W.
1994
35 9 p. 620-621
2 p.
artikel
220 Is a double-blind drug study really double blind? Quak, J.
1994
35 9 p. 741-
1 p.
artikel
221 Is free radical pathology of any consequence in schizophrenia and its treatment Reddy, R.
1994
35 9 p. 700-
1 p.
artikel
222 Is frontal lobe dysfunction really generalized deficit in schizophrenia? Bell, L.
1994
35 9 p. 635-636
2 p.
artikel
223 Is PSIM-E increased in winter depression? Avery, D.H.
1994
35 9 p. 668-
1 p.
artikel
224 Is there rapid relapse after discontinuation of clozapine? Musser, W.S.
1994
35 9 p. 742-
1 p.
artikel
225 I.V. glycine/d-cycloserine to facilitate NMDA function in humans D'Souza, D.C.
1994
35 9 p. 734-
1 p.
artikel
226 Latent structure of the hamilton depression rating scale in schizophrenia Goldman, R.S.
1994
35 9 p. 694-
1 p.
artikel
227 Laterality, thought disorder, and memory in schizophrenia Manschreck, T.C.
1994
35 9 p. 633-
1 p.
artikel
228 Left superior temporal gyrus dysfunction and auditory hallucinations in schizophrenia: A cognitive neuropsychological study Carter, C.S.
1994
35 9 p. 659-
1 p.
artikel
229 LH and FSH response to submaximal GnRH stimulation in depressed and healthy subjects Amsterdam, J.D.
1994
35 9 p. 651-652
2 p.
artikel
230 Links between delta-EEG intensity and thermoregulatory drive Eder, D.N.
1994
35 9 p. 671-672
2 p.
artikel
231 Local cerebral blood flow during memory activation in healthy controls and patients with schizophrenia Gur, R.C.
1994
35 9 p. 622-
1 p.
artikel
232 Localization of interleukin 1 type I receptor mRNA in rat brain Licinio, J.
1994
35 9 p. 732-
1 p.
artikel
233 Localization of the functional effects of apomorphine—A pet study in humans Kapur, S.
1994
35 9 p. 682-
1 p.
artikel
234 Longitudinal classification in schizophrenia: The relationship between kraepelinian and deficit syndrome subtypologies Apter, S.H.
1994
35 9 p. 695-
1 p.
artikel
235 Long-term cocaine administration alters basal cerebral metabolic rate Hammer Jr., R.P.
1994
35 9 p. 624-
1 p.
artikel
236 Low-dose TRH effects in ECT postictal state Khan, A.
1994
35 9 p. 654-
1 p.
artikel
237 Low plasma GABA is a stable trait marker of mood disorders Petty, F.
1994
35 9 p. 729-
1 p.
artikel
238 Low plasma homovanillic acid (HVA) at the onset of psychosis Scheffer, R.
1994
35 9 p. 701-702
2 p.
artikel
239 Low urinary cortisol excretion in holocaust survivors with posttraumatic stress disorder Yehuda, R.
1994
35 9 p. 710-711
2 p.
artikel
240 L-thyroxine augmentation of valproate treatment of rapid cycling bipolar disorder Mandoki, M.W.
1994
35 9 p. 730-
1 p.
artikel
241 Magnesium: Modulation by mood and menstrual cycle Rosenstein, D.
1994
35 9 p. 661-
1 p.
artikel
242 Maintenance ECT as adjunctive treatment to dopaminergic drugs in Parkinson's disease Serby, M.
1994
35 9 p. 654-
1 p.
artikel
243 Marked increases in USA marijuana and LSD: Results of annual junior and senior high school survey Gold, M.S.
1994
35 9 p. 694-
1 p.
artikel
244 Maximally tolerated dose of the muscarinic agonist CI-979 in Alzheimer's disease (AD) Cutler, N.R.
1994
35 9 p. 628-
1 p.
artikel
245 Measuring neurocognitive change Obuchowski, M.
1994
35 9 p. 637-
1 p.
artikel
246 Mediation of estrogen and neurotrophin actions through their interactions? Toran-Allerand, C.D.
1994
35 9 p. 618-619
2 p.
artikel
247 Medical comorbidities and hospitalization mania Fogel, B.
1994
35 9 p. 626-
1 p.
artikel
248 Melatonin, a novel marker to characterize presynaptic catecholamine depletion Krahn, L.E.
1994
35 9 p. 668-
1 p.
artikel
249 Membrane fatty acid composition of fibroblasts from schizophrenic patients Mukherjee, S.
1994
35 9 p. 700-701
2 p.
artikel
250 Mesolimbic dopamine D3 receptors: elevation in schizophrenics Gurevich, E.V.
1994
35 9 p. 716-
1 p.
artikel
251 Methadone withdrawal psychosis Levinson, I.
1994
35 9 p. 692-
1 p.
artikel
252 Minimum effective dose of haloperidol in treatment of psychoses Garver, D.L.
1994
35 9 p. 667-
1 p.
artikel
253 Mixed bipolar states at first hospitalization Suppes, T.
1994
35 9 p. 625-
1 p.
artikel
254 Modulation of neuronal activity by a serotonergic agonist: A pet study in humans Brown, G.
1994
35 9 p. 682-
1 p.
artikel
255 Mononuclear leukocyte G-protein in depressed subjects Young, L.T.
1994
35 9 p. 726-727
2 p.
artikel
256 Mood disoders with postpartum onset: A family study Steiner, M.
1994
35 9 p. 729-
1 p.
artikel
257 Movement disorders in schizophrenic substance abusers Lawson, W.B.
1994
35 9 p. 731-
1 p.
artikel
258 MRI and ERP evidence for a neurodegenerative course in schizophrenia O'Donnell, B.F.
1994
35 9 p. 704-
1 p.
artikel
259 MRI changes in elderly schizophrenic, depressive, and control subjects Keshavan, M.S.
1994
35 9 p. 705-
1 p.
artikel
260 MRI changes with water loading in polydipsia/hyponatremia Leadbetter, R.
1994
35 9 p. 702-
1 p.
artikel
261 MRI measures in adolescent schizophrenics: comparison to controls Friedman, L.
1994
35 9 p. 713-
1 p.
artikel
262 MRI volumetrics in late life depression and alzheimer's disease Kumar, A.
1994
35 9 p. 665-
1 p.
artikel
263 Mutation screening of the 5-HT2A receptor in children with autistic disorder and their first-degree relatives Cook, E.H.
1994
35 9 p. 724-
1 p.
artikel
264 Naltrexone induced increase in insulin requirement Marrazzi, M.A.
1994
35 9 p. 736-
1 p.
artikel
265 Naltrexone in the treatment of anorexia and bulimia nervosa Marrazzi, M.A.
1994
35 9 p. 735-
1 p.
artikel
266 Negative symptoms in antipsychotic-naive schizophrenics and the effect of haloperidol Miller, D.D.
1994
35 9 p. 746-
1 p.
artikel
267 Negative symptoms in immunologically abnormal clusters of schizophrenics Ganguli, R.
1994
35 9 p. 726-
1 p.
artikel
268 Negative symptoms in patients with Alzheimer's disease Galynker, I.
1994
35 9 p. 628-
1 p.
artikel
269 Negative symptoms in patients with basal ganglia strokes Galynker, I.
1994
35 9 p. 681-682
2 p.
artikel
270 Neonatal hippocampal damage disrupts sensorimotor gating in postpubertal rats Lipska, B.K.
1994
35 9 p. 631-632
2 p.
artikel
271 Neuroanatomical localization of ketamine-induced psychosis in schizophrenic patients and controls Breier, A.
1994
35 9 p. 704-
1 p.
artikel
272 Neuroendocrine and circadian modulation by the menstrual cycle Leibenluft, E.
1994
35 9 p. 662-
1 p.
artikel
273 Neuroendocrine profiles of antipsychotic drugs in schizophrenic patients Duval, F.
1994
35 9 p. 649-
1 p.
artikel
274 Neuroleptic effects on CPT and eye tracking in schizophrenia Epstein, J.I.
1994
35 9 p. 674-
1 p.
artikel
275 Neurologic abnormalities in schizophrenia Ames, D.
1994
35 9 p. 714-
1 p.
artikel
276 Neurological soft signs in schizophrenia: relationship to thought disorder Duncan, E.
1994
35 9 p. 715-
1 p.
artikel
277 Neurologic deficits, Tardive dyskinesia, and medication status Ames, D.
1994
35 9 p. 715-
1 p.
artikel
278 Neurologic soft signs in neuroleptic naive patients Gupta, S.
1994
35 9 p. 715-
1 p.
artikel
279 Neurologic soft signs in schizophrenia Clark, S.C.
1994
35 9 p. 714-
1 p.
artikel
280 Neuropeptides discriminate brains of schizophrenics from normals Powchik, P.
1994
35 9 p. 733-
1 p.
artikel
281 Neuropsychiatric effects of perimenopausal estrogen replacement Schmidt, P.J.
1994
35 9 p. 662-
1 p.
artikel
282 Neuropsychoimmunology: Role of behavior Rotenberg, V.S.
1994
35 9 p. 725-
1 p.
artikel
283 Neuropsychological characteristics of individuals at risk for alcoholism: A meta-analysis Pollock, V.E.
1994
35 9 p. 691-692
2 p.
artikel
284 Neuropsychological correlates of abnormal spect findings in schizophrenics Dewan, M.
1994
35 9 p. 636-
1 p.
artikel
285 Neuropsychological correlates of MRI measures in schizophrenia Nestor, P.G.
1994
35 9 p. 722-
1 p.
artikel
286 Neuropsychological deficits in adolescents and adult schizophrenics Smith, A.
1994
35 9 p. 635-
1 p.
artikel
287 Neuropsychological differences between schizophrenia and temporal lobe epilepsy Gold, J.
1994
35 9 p. 635-
1 p.
artikel
288 Neuropsychological function and novel P300 in schizophrenics Merrin, E.L.
1994
35 9 p. 616-
1 p.
artikel
289 Neuropsychological impairments in adolescent schizophrenics Kenny, J.T.
1994
35 9 p. 712-
1 p.
artikel
290 Neuropsychological performance in schizophrenic inpatients as a function of medication status Smet, I.C.
1994
35 9 p. 666-
1 p.
artikel
291 Neuropsychology of OCD: Preliminary findings Aronowitz, B.R.
1994
35 9 p. 638-
1 p.
artikel
292 Normal response to AM metyrapone administration in depressed patients Young, E.A.
1994
35 9 p. 711-
1 p.
artikel
293 Notices 1994
35 9 p. vii-x
nvt p.
artikel
294 Observing thought disorder and information-processing deficits in schizophrenia through parallel measurement Perry, W.
1994
35 9 p. 633-
1 p.
artikel
295 Obsessive-compulsive and bipolar disorder: Preliminary outcome data McKay, D.R.
1994
35 9 p. 738-
1 p.
artikel
296 Olanzapine: A novel antipsychotic with a broad spectrum profile Tollefson, G.D.
1994
35 9 p. 746-747
2 p.
artikel
297 On the possibilities of nonmedicamentous treatment of anxiety disorders Suija, R.
1994
35 9 p. 738-739
2 p.
artikel
298 Open cross-over study with fluoxetine and desipramine in major depression Ontiveros, A.
1994
35 9 p. 677-
1 p.
artikel
299 Orbital frontal cortex metabolism and obsessionality in normal volunteers Kraft, L.W.
1994
35 9 p. 684-
1 p.
artikel
300 Oxytocin shows a diurnal rhythm in CSF of healthy volunteers Kling, M.A.
1994
35 9 p. 734-
1 p.
artikel
301 Panic disorder: Growth hormone and IGF responses to exercise Gadde, K.M.
1994
35 9 p. 738-
1 p.
artikel
302 Paroxetine for the treatment of premenstrual dysphoric disorder Yonkers, K.A.
1994
35 9 p. 652-
1 p.
artikel
303 Paroxysmal-like EEG abnormalities associated with chronic polydrug abuse Cornwell, A.
1994
35 9 p. 692-693
2 p.
artikel
304 Pathophysiology of neuronal activation Gjedde, A.
1994
35 9 p. 657-
1 p.
artikel
305 Penetrating arterioles, the phi-loop, and the functional psychoses Cowen, M.A.
1994
35 9 p. 699-
1 p.
artikel
306 Perceptual organization in acute and remitted schizophrenic patients Silverstein, S.M.
1994
35 9 p. 633-634
2 p.
artikel
307 Pet O-15 sympton provocation studies of anxiety disorders Rauch, S.L.
1994
35 9 p. 658-
1 p.
artikel
308 Pet studies of regional cerebral blood flow during tasks assessing attention, language and memory in schizophrenics and normal controls Andreasen, N.C.
1994
35 9 p. 657-
1 p.
artikel
309 Pharmaco-EEG studies of single doses of an atypical neuroleptic iloperidone, compared with chlorpromazine and placebo in schizophrenic patients Milstein, V.
1994
35 9 p. 671-
1 p.
artikel
310 Pharmacological responsiveness of [3H]GBR 12935 binding sites in the prefrontal cortex of cocaine using humans and rats Hitri, A.
1994
35 9 p. 733-734
2 p.
artikel
311 Pharmacotherapy of anxiety disorders Goodman, W.K.
1994
35 9 p. 620-
1 p.
artikel
312 31 Phosphorous MRSI of the temporal lobes in chronic schizophrenia Deicken, R.F.
1994
35 9 p. 703-
1 p.
artikel
313 Physical versus social anhedonia in the measurement of psychosis proneness Schwarzkopf, S.B.
1994
35 9 p. 697-
1 p.
artikel
314 Physostigmine: Dissociation of mood and psychomotor effects in healthy males Silva, S.G.
1994
35 9 p. 666-
1 p.
artikel
315 Pituitary response to TRH in young men at risk for alcoholism Garbutt, J.C.
1994
35 9 p. 692-
1 p.
artikel
316 Pituitary size in seasonal affective disorder: A controlled study Calil, H.M.
1994
35 9 p. 669-
1 p.
artikel
317 Placebo-controlled study of a CCKB antagonist in patients with panic disorder Cutler, N.R.
1994
35 9 p. 680-
1 p.
artikel
318 Placebo-controlled study of MDL 11,939 in patients with generalized anxiety disorder Cutler, N.R.
1994
35 9 p. 680-681
2 p.
artikel
319 Platelet benzodiazepine receptors in post traumatic stress disorder Diamond, B.
1994
35 9 p. 656-
1 p.
artikel
320 Polysomnographic distinction of Alzheimer's disease. major depression & healthy controls Bahro, M.
1994
35 9 p. 627-628
2 p.
artikel
321 Positive/negative symptoms in schizophrenia: Spect activation studies Losonczy, M.
1994
35 9 p. 685-
1 p.
artikel
322 Postnatal remodeling of monkey prefrontal cortical circuitry Anderson, S.A.
1994
35 9 p. 706-
1 p.
artikel
323 Post-stroke bipolar disorders: age and the thalamus Lauterbach, E.C.
1994
35 9 p. 681-
1 p.
artikel
324 Post-stroke generalized anxiety: Parkinsonism, dystonia, & the globus pallidus Lauterbach, E.C.
1994
35 9 p. 681-
1 p.
artikel
325 Post-stroke major depression: Parkinsonism and thalamocortical systems relations Lauterbach, E.C.
1994
35 9 p. 681-
1 p.
artikel
326 Post-synaptic camp-dependent protein kinase participates in longterm potentiation Landau, E.M.
1994
35 9 p. 733-
1 p.
artikel
327 Potent interactions between NE and 5-HT systems Aston-Jones, G.
1994
35 9 p. 621-
1 p.
artikel
328 P1 recovery cycle abnormalities and clinical phenomenology in schizophrenia Erwin, R.J.
1994
35 9 p. 616-
1 p.
artikel
329 Predictive bio-clinical profiles of antidepressant responses in depression Duval, F.
1994
35 9 p. 678-
1 p.
artikel
330 Predictive validity of FSL rat, an animal model of depression Overstreet, D.H.
1994
35 9 p. 706-
1 p.
artikel
331 Predictors of cocaine-induced paranoia Rosse, R.B.
1994
35 9 p. 694-
1 p.
artikel
332 Predictors of tardive dyskinesia in first episode schizophrenia Chakos, M.H.
1994
35 9 p. 714-
1 p.
artikel
333 Premature disinhibition of visual P3 in schizophrenia Shelley, A.M.
1994
35 9 p. 673-674
2 p.
artikel
334 Premorbid history and clinical manifestations at the onset of psychosis Scheffer, R.
1994
35 9 p. 695-696
2 p.
artikel
335 Prescribing characteristics of three SSRIs in a Department of veterans affairs psychiatry clinic Adler, L.A.
1994
35 9 p. 655-
1 p.
artikel
336 Prescription patterns in hospitalized patients with refractory psychoses Roy, J.-Y.
1994
35 9 p. 744-
1 p.
artikel
337 P50 responses in normal subjects with sensory overloading Jin, Y.
1994
35 9 p. 631-
1 p.
artikel
338 Prevalence and correlates of stable negative symptom subtypes in geriatric chronic schizophrenic inpatients Putnam, K.M.
1994
35 9 p. 640-
1 p.
artikel
339 PRL and HVA responses to D- and D,L-fenfluramine in humans Coccaro, E.F.
1994
35 9 p. 644-
1 p.
artikel
340 “Probing” the nature of CPT deficits in schizophrenia with blink modification Hazlett, E.A.
1994
35 9 p. 674-675
2 p.
artikel
341 Promising medications not available in the United States Glick, I.D.
1994
35 9 p. 678-
1 p.
artikel
342 Prospective study of mood and anxiety changes during pregnancy and postpartum Altemus, M.
1994
35 9 p. 661-
1 p.
artikel
343 Protection of tau from hyperphosphorylation by heat shock proteins in neuronal PC 12 cells Wallace, W.
1994
35 9 p. 663-
1 p.
artikel
344 Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia Fujimoto, T.
1994
35 9 p. 686-
1 p.
artikel
345 Proton mrs of the basal ganglia in bipolar disorder Lafer, B.
1994
35 9 p. 685-
1 p.
artikel
346 Proton mrs of the basal ganglia in major depression Renshaw, P.F.
1994
35 9 p. 685-
1 p.
artikel
347 Psychiatric and personality variables in the MVP-PD relationship Aronowitz, B.R.
1994
35 9 p. 697-698
2 p.
artikel
348 Psychiatric comorbidities and hospitalization for mania Fogel, B.
1994
35 9 p. 729-
1 p.
artikel
349 Psychiatric sequelae of low birth weight at 6 years of age Breslau, Naomi
1994
35 9 p. 723-
1 p.
artikel
350 Psychometric correlates OP platelet serotonergic abnormalities in PTSD Fichtner, C.G.
1994
35 9 p. 654-655
2 p.
artikel
351 Psychotropic effects of steroid synthesis inhibitors in refractory depression Ghadirian, A.M.
1994
35 9 p. 618-
1 p.
artikel
352 Putamen volume reduction viewed by MRI in mild Huntington's disease Harris, G.J.
1994
35 9 p. 664-
1 p.
artikel
353 Quantitative analysis of EEG in Vietnam veterans with and without PTSD Paige, S.R.
1994
35 9 p. 655-
1 p.
artikel
354 Quantitative autoradiography of dopamine D4 receptors in postmortem brains from schizophrenic patients Murray, A.M.
1994
35 9 p. 716-
1 p.
artikel
355 Quantitative EEG measures: correlations with lieetime exposure to cocaine, alcohol, and marijuana in chronic polydrug abusers Roemer, R.A.
1994
35 9 p. 624-625
2 p.
artikel
356 Quantitative in vitro NMR analysis of Alzheimer's, non-Alzheimer's demented and control brain Klunk, W.E.
1994
35 9 p. 627-
1 p.
artikel
357 Quantitative magnetic resonance imaging of human brain development: ages 4–18 Giedd, J.N.
1994
35 9 p. 713-
1 p.
artikel
358 Quantitative morphology of the caudate nucleus in ADHD Castellanos, F.X.
1994
35 9 p. 725-
1 p.
artikel
359 Random assignment to three haloperidol plasma levels for acute psychosis Janicak, P.G.
1994
35 9 p. 666-
1 p.
artikel
360 rCBF (015 PET) during cognitive and physiological stimulation in schizophrenics Ganguli, R.
1994
35 9 p. 621-622
2 p.
artikel
361 Reaction to sodium lactate infusion in perpetrators of domestic violence George, D.T.
1994
35 9 p. 737-
1 p.
artikel
362 Reduced dopamine uptake sites in homozygous Cu/Zn super-oxide dismutase transgenic mice Boja, J.W.
1994
35 9 p. 732-
1 p.
artikel
363 Reduced hospitalization with clozapine in a community mental health setting Ganguli, R.
1994
35 9 p. 742-
1 p.
artikel
364 5α-reductase in glial cells, sexual orientation, and fluid intelligence Alias, A.G.
1994
35 9 p. 735-
1 p.
artikel
365 Reduction of amphetamine-induced dyskinesia in schizophrenia spectrum subjects Cassady, S.L.
1994
35 9 p. 665-
1 p.
artikel
366 Regional blood flow correlates of transient self-induced sadness or happiness George, M.S.
1994
35 9 p. 647-
1 p.
artikel
367 Regional cerebral blood flow in OCD patients before and during treatment Rubin, R.T.
1994
35 9 p. 647-
1 p.
artikel
368 Regulation of immediate early gene expression in the CNS by antipsychotics Rogue, P.
1994
35 9 p. 688-
1 p.
artikel
369 Relationship between DST findings and polysomnographic abnormalities in schizophrenia Tandon, R.
1994
35 9 p. 675-676
2 p.
artikel
370 Relationship between salivary gland size & hyperamylasemia in bulimia nervosa Metzger, E.D.
1994
35 9 p. 736-
1 p.
artikel
371 Relationships between temporal and frontal brain volume in schizophrenics Wible, C.G.
1994
35 9 p. 722-
1 p.
artikel
372 Responsiveness to stress in major depression Platt, J.E.
1994
35 9 p. 730-
1 p.
artikel
373 Resting baseline topography of local cerebral glucose utilization in patients with schizophrenia Gur, R.E.
1994
35 9 p. 687-688
2 p.
artikel
374 rG-CSF treatment of clozapine-induced agranulocytosis Lamberti, J.S.
1994
35 9 p. 745-
1 p.
artikel
375 Risk prediction in schizophrenia using cognitive measures Manschreck, T.C.
1994
35 9 p. 697-
1 p.
artikel
376 (R)-, (S)-, and (RS)-Fluoxetine: Relative anorectic efficacy in the rat Schneider, L.H.
1994
35 9 p. 733-
1 p.
artikel
377 [125]RTI-55, a high affinity cocaine analog, labels two binding sites in human caudate membranes possibly related to the 5-HT transporter Silverthom, M.L.
1994
35 9 p. 644-
1 p.
artikel
378 Safety, tolerance, pharmacokinetic and RBC cholinesterase activity of MDL 73,745 Cutler, N.R.
1994
35 9 p. 680-
1 p.
artikel
379 Schizophrenia: head size correlates with 2nd Trimester markers Bracha, H.S.
1994
35 9 p. 723-
1 p.
artikel
380 Schizophrenic dementia: Racial issues Lawson, W.B.
1994
35 9 p. 702-
1 p.
artikel
381 Screening for executive cognitive dysfunction in bipolar disorder Bauer, M.
1994
35 9 p. 636-
1 p.
artikel
382 Selective breeding for serotonin-1A-induced hypothermia Overstreet, D.H.
1994
35 9 p. 642-643
2 p.
artikel
383 Selective modulation of the serotonin 1A receptor by steroids and stress López, J.F.
1994
35 9 p. 712-
1 p.
artikel
384 Selective pattern of cognitive functioning in autism: A function of information processing load Minshew, N.J.
1994
35 9 p. 632-
1 p.
artikel
385 Sensorimotor gating of the human startle reflex: Gender and laterality Swerdlow, N.R.
1994
35 9 p. 616-
1 p.
artikel
386 Sensory gating and schizophrenia: Critical methodological issues Braff, D.L.
1994
35 9 p. 629-
1 p.
artikel
387 Serotonergic and adrenergic platelet markers in PTSD Crayton, J.W.
1994
35 9 p. 655-
1 p.
artikel
388 Serotonergic challenge responses in women with a history of bulimia nervosa Wolfe, B.E.
1994
35 9 p. 736-737
2 p.
artikel
389 Serotonergic responsivity in borderline personality disorder Stein, D.J.
1994
35 9 p. 644-
1 p.
artikel
390 Serotonergic responsivity in trichotillomania Stein, D.J.
1994
35 9 p. 645-
1 p.
artikel
391 Serotonin and impulsive/ aggressive behavior in parolees with and without a history of violence Moeller, F.G.
1994
35 9 p. 646-
1 p.
artikel
392 Serotonin and self-directed aggression in personality disorders New, A.S.
1994
35 9 p. 645-646
2 p.
artikel
393 Serotonin, norepinephrine, or both, in anxiety? Goddard, A.W.
1994
35 9 p. 621-
1 p.
artikel
394 Serum cholesterol and impulsivity in mood and personality disorders New, A.S.
1994
35 9 p. 739-740
2 p.
artikel
395 Severe premenstrual dysphoria, affective disorders and the DSM-IV Steiner, M.
1994
35 9 p. 650-
1 p.
artikel
396 Short REM latency and dexamethasone nonsuppression in schizophrenia: Due to an affective diathesis? Goldman, M.
1994
35 9 p. 673-
1 p.
artikel
397 Similar effects of stimulants on latent inhibition and prepulse inhibition Bakshi, V.P.
1994
35 9 p. 631-
1 p.
artikel
398 Single-trial P50 in normal and schizophrenic subjects Jin, Y.
1994
35 9 p. 631-
1 p.
artikel
399 Sleep architecture changes across the menstrual cycle Yonkers, K.A.
1994
35 9 p. 652-
1 p.
artikel
400 Sleep disturbance induced by a sibgle stressful event in an animal model: relevance to PTSD? Weiss, J.M.
1994
35 9 p. 710-
1 p.
artikel
401 Small molecule beta-amyloid probes which distinguish homogenates of Alzheimer's and control brains Klunk, W.E.
1994
35 9 p. 627-
1 p.
artikel
402 Small neuronal size in hippocampal subfields that mediate cortical-hippocampal interactions Arnold, S.E.
1994
35 9 p. 717-
1 p.
artikel
403 Smoking and risk for tardive dyskinesia Caliguiri, M.P.
1994
35 9 p. 731-
1 p.
artikel
404 Smooth pursuit and predictive saccadic tracking in patients with OCD Clementz, B.A.
1994
35 9 p. 674-
1 p.
artikel
405 Smooth pursuit eye tracking in monozygotic twins discordant for schizophrenia Litman, R.
1994
35 9 p. 660-
1 p.
artikel
406 Society information 1994
35 9 p. v-vi
nvt p.
artikel
407 Society of biological psychiatry 1994
35 9 p. iii-
1 p.
artikel
408 Society of biological psychiatry 1994
35 9 p. iv-
1 p.
artikel
409 Society of Biological Psychiatry 1994 Annual Meeting 1994
35 9 p. 579-614
36 p.
artikel
410 Sodium lactate infusion in patients with epilepsy and panic attacks Ontiveros, A.
1994
35 9 p. 676-
1 p.
artikel
411 Soft signs, attention, and startle in schizophrenia Karper, L.
1994
35 9 p. 714-
1 p.
artikel
412 Somatostatin antibodies react with DNA binding sequence of the thyroid receptor Roy, B.
1994
35 9 p. 727-
1 p.
artikel
413 Some effects of folate deficiency on mentals status in street dwelling homeless mentally ill Alpert, M.
1994
35 9 p. 699-
1 p.
artikel
414 Spatial relationships of neuroanatomic landmarks in schizophrenia DeQuardo, J.R.
1994
35 9 p. 718-719
2 p.
artikel
415 Specificity of anxiety symptoms in the post-stroke period Castillo, C.S.
1994
35 9 p. 682-
1 p.
artikel
416 Spect diamox response augmented in cocaine dependent patients Bell, K.M.
1994
35 9 p. 683-
1 p.
artikel
417 Spect findings in narcolepsy Shettar, S.
1994
35 9 p. 684-
1 p.
artikel
418 Stable manual dexterity disturbance in asymptomatic HIV-1 seropositive gay men: A 12-month follow-up Silva, S.G.
1994
35 9 p. 638-
1 p.
artikel
419 Startle gating after frontal cortex or hippocampal lesions in adult rats Swerdlow, N.
1994
35 9 p. 707-
1 p.
artikel
420 Stimulus and response conflict in schizophrenia Taylor, S.F.
1994
35 9 p. 642-
1 p.
artikel
421 Stress and brain norepinephrine:in vivo dialysis studies Abercrombie, E.D.
1994
35 9 p. 710-
1 p.
artikel
422 Stress-induced alterations in plasma cortisol, norepinephrine and emotion Gruen, R.J.
1994
35 9 p. 678-
1 p.
artikel
423 Suicidal behavior among twins Roy, A.
1994
35 9 p. 668-
1 p.
artikel
424 Sulcal volume and prominence in first episode schizophrenia Wu, H.
1994
35 9 p. 713-714
2 p.
artikel
425 Superior Temporal Gyral Volume in schizophrenia Reite, M.
1994
35 9 p. 718-
1 p.
artikel
426 Suppressibility and recovery of the thyroid axis in depression Stokes, P.E.
1994
35 9 p. 651-
1 p.
artikel
427 Suppression of HPA axis response to stress in lactating women Altemus, M.
1994
35 9 p. 650-
1 p.
artikel
428 Sympathetic nervous system function in post-traumatic stress disorder Murburg, M.M.
1994
35 9 p. 709-710
2 p.
artikel
429 Temporal and age disorientation are primary features of cognitive impairment in geriatric schizophrenic inpatients Harvey, P.D.
1994
35 9 p. 639-
1 p.
artikel
430 Temporal stability of neurological signs in first-episode psychotic patients Scheffer, R.
1994
35 9 p. 715-
1 p.
artikel
431 Testing definitions of dysphoric mania and hypomania Bauer, M.
1994
35 9 p. 696-
1 p.
artikel
432 The action of venlafaxine on obsessive-compulsive disorder Yaryura-Tobias, J.A.
1994
35 9 p. 737-
1 p.
artikel
433 The antioxidant defense system at the onset of psychosis Mukherjee, S.
1994
35 9 p. 701-
1 p.
artikel
434 The autonomic orienting response in schizophrenia and mania Schnur, D.B.
1994
35 9 p. 632-633
2 p.
artikel
435 The BE(2)-C cell secretes corticotropin-releasing factor and responds to forskolin Kasckow, J.W.
1994
35 9 p. 663-
1 p.
artikel
436 The brainstem and psychosis Howland, R.H.
1994
35 9 p. 700-
1 p.
artikel
437 The consequences of nocturnal REM deprivation on the level of daytime sleepiness Rosenthal, L.
1994
35 9 p. 672-673
2 p.
artikel
438 The developmental plasticity of the dopamine systems in the rodent basal ganglia Frohna, P.A.
1994
35 9 p. 688-
1 p.
artikel
439 The effect of ECT on quantitative EEG and spect measures Konopka, L.M.
1994
35 9 p. 653-
1 p.
artikel
440 The effect of sex, age and pCO2 on cerebral blood flow during cognitive stimulation Esposito, G.
1994
35 9 p. 648-
1 p.
artikel
441 The effect of triazolam on visual attention and information processing Johnson, D.N.
1994
35 9 p. 641-
1 p.
artikel
442 The effects of amphetamine on shifts in visual attention Moran, M.J.
1994
35 9 p. 640-641
2 p.
artikel
443 The effects of chronic psychosis on rivermead behavioral memory test performance Cloud, B.S.
1994
35 9 p. 637-
1 p.
artikel
444 The effects of delayed auditory feedback on speech in schizophrenia Goldberg, T.E.
1994
35 9 p. 659-
1 p.
artikel
445 The effects of ketamine on behavioral, cognitive and neuroendocrine function in schizophrenia Malhotra, A.K.
1994
35 9 p. 651-
1 p.
artikel
446 The effects of neuroleptic dose adjustment on D2 receptor occupancy and schizophrenic symptomatology, a study using IBZM spect Su, T.P.
1994
35 9 p. 689-
1 p.
artikel
447 The efficacy of the partial dopamine agonist (-)-3PPP in schizophrenia Lahti, A.C.
1994
35 9 p. 746-
1 p.
artikel
448 The factor structure of schizotypy Bergman, A.
1994
35 9 p. 740-
1 p.
artikel
449 The half-age stimulation strategy for bilateral ECT Petrides, G.
1994
35 9 p. 653-
1 p.
artikel
450 The longitudinal stability of cognitive impairment in schizophrenia: Mini mental scores at one and two year follow-ups in geriatric inpatients Harvey, P.D.
1994
35 9 p. 639-
1 p.
artikel
451 The neural basis of abstract reasoning: An investigation of two problem solving tasks with pet Ostrem, J.L.
1994
35 9 p. 686-
1 p.
artikel
452 The neuroanatomical basis of psychopathology: The decade of the brain Kleinman, Joel E.
1994
35 9 p. xi-
1 p.
artikel
453 The prediction of clozapine discontinuation Moeller, F.G.
1994
35 9 p. 743-
1 p.
artikel
454 The role of the frontal lobe during maze learning assessed using pet Van Horn, J.D.
1994
35 9 p. 686-
1 p.
artikel
455 The roles of the dorsolateral prefrontal cortex and hippocampus in working memory and schizophrenia Berman, K.F.
1994
35 9 p. 622-
1 p.
artikel
456 The stability and agreement of general impairment indicators in schizophrenia Tracy, J.
1994
35 9 p. 637-
1 p.
artikel
457 Three Dimensional functional MRI in schizophrenics and normal volunteers performing the Wisconsin card sorting test Kotrla, K.J.
1994
35 9 p. 623-
1 p.
artikel
458 Timing and amplitude during predictive saccadic tracking in schizophrenia McDowell, J.E.
1994
35 9 p. 676-
1 p.
artikel
459 Topography of limbic dopamine uptake sites in human and rat brain Little, K.Y.
1994
35 9 p. 690-
1 p.
artikel
460 Training raters to assess neuroleptic-induced akathisia using standardized videotapes Adler, L.A.
1994
35 9 p. 696-
1 p.
artikel
461 Transforming growth factor beta, the phi-loop, and the schizophrenias Cowen, M.
1994
35 9 p. 699-
1 p.
artikel
462 Treatment of axial dystonia with clozapine Wolf, M.E.
1994
35 9 p. 743-
1 p.
artikel
463 Treatment resistant depression: Clinical characteristics Dunner, D.L.
1994
35 9 p. 617-
1 p.
artikel
464 Tryptophan depletion paradigm: Implications for schizophrenia D'Souza, D.C.
1994
35 9 p. 703-
1 p.
artikel
465 Unsuspected physical sleep disorders in PTSD Douglas, A.B.
1994
35 9 p. 656-
1 p.
artikel
466 Uric acid level increases in humanswho are gambling: A preliminary report Manowitz, P.
1994
35 9 p. 698-
1 p.
artikel
467 Urine concentration of creatinine: Comparison of methods to detect polyuria Verghese, C.
1994
35 9 p. 702-703
2 p.
artikel
468 Use of 3D MR surface renderings for measuring planum temporale Shenton, M.E.
1994
35 9 p. 721-
1 p.
artikel
469 Valproate-carbamazepine combination in the treatment of children and adolescents Mandoki, M.W.
1994
35 9 p. 724-
1 p.
artikel
470 Ventricular volumes in patients with temporal lobe epilepsy and psychosis Umbricht, D.
1994
35 9 p. 718-
1 p.
artikel
471 Verapamil for acute mania: Preliminary results from a double-blind, placebo-controlled study Janicak, P.G.
1994
35 9 p. 679-
1 p.
artikel
472 Verbal memory and resting cerebral glucose metabolism in schizophrenia Mozley, L.H.
1994
35 9 p. 658-
1 p.
artikel
473 Visual backward masking as a phenotypic marker in schizophrenic spectrum individuals Cadenhead, K.S.
1994
35 9 p. 642-
1 p.
artikel
474 Visual organization, memory and thought disorder in schizophrenia Osborn, L.M.
1994
35 9 p. 633-
1 p.
artikel
475 Visuospatial skill learning and CT correlates in alcoholism Schwartz, B.L.
1994
35 9 p. 693-694
2 p.
artikel
476 Vitamin E treatment of TD: Development of a VA cooperative study Adler, L.A.
1994
35 9 p. 730-731
2 p.
artikel
477 Volume of the superior temporal gyrus in patients with schizophrenia and normal controls: an investigation utilizing three-dimensional MRI surface-rendering morphometry Kulynych, J.J.
1994
35 9 p. 722-
1 p.
artikel
478 Voluntary and involuntary attentional deficits in schizophrenia Braff, D.L.
1994
35 9 p. 615-
1 p.
artikel
479 When do patients respond to tricyclic antidepressants? Rush, A.J.
1994
35 9 p. 711-
1 p.
artikel
480 Withdrawal from chronic cocaine is associated with changes in presynaptic serotonergic function in rats Baumann, M.H.
1994
35 9 p. 643-
1 p.
artikel
481 Withdrawn 1994
35 9 p. 656-
1 p.
artikel
482 Withdrawn 1994
35 9 p. 685-
1 p.
artikel
483 Withdrawn 1994
35 9 p. 635-
1 p.
artikel
484 Withdrawn 1994
35 9 p. 745-
1 p.
artikel
485 Working memory dysfunction in Kraepelinian schizophrenics Keefe, R.S.E.
1994
35 9 p. 660-
1 p.
artikel
                             485 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland